314 related articles for article (PubMed ID: 15931643)
1. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
[TBL] [Abstract][Full Text] [Related]
2. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
[TBL] [Abstract][Full Text] [Related]
3. Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity.
De Muro P; Faedda R; Satta AE; Masala A; Cigni A; Falconi D; Sanna GM; Cherchi GM
Scand J Urol Nephrol; 2007; 41(3):230-6. PubMed ID: 17469033
[TBL] [Abstract][Full Text] [Related]
4. Urinary endothelin in glomerulonephritis patients with normal renal function.
Roccatello D; Mosso R; Ferro M; Polloni R; De Filippi PG; Quattrocchio G; Bancale E; Cesano G; Sena LM; Piccoli G
Clin Nephrol; 1994 Jun; 41(6):323-30. PubMed ID: 8076434
[TBL] [Abstract][Full Text] [Related]
5. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
Taira K; Hewitson TD; Kincaid-Smith P
Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
[TBL] [Abstract][Full Text] [Related]
6. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
Tencer J; Torffvit O; Björnsson S; Thysell H; Grubb A; Rippe B
Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
[TBL] [Abstract][Full Text] [Related]
7. Urinary glycosaminoglycans in patients with systemic lupus erythematosus.
De Muro P; Faedda R; Formato M; Re F; Satta A; Cherchi GM; Carcassi A
Clin Exp Rheumatol; 2001; 19(2):125-30. PubMed ID: 11326473
[TBL] [Abstract][Full Text] [Related]
8. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases.
Mitsuhashi H; Tsukada Y; Ono K; Yano S; Naruse T
Clin Nephrol; 1993 May; 39(5):231-8. PubMed ID: 8513598
[TBL] [Abstract][Full Text] [Related]
9. Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases.
Achenbach J; Mengel M; Tossidou I; Peters I; Park JK; Haubitz M; Ehrich JH; Haller H; Schiffer M
Nephrol Dial Transplant; 2008 Oct; 23(10):3138-45. PubMed ID: 18458033
[TBL] [Abstract][Full Text] [Related]
10. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR
Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
[TBL] [Abstract][Full Text] [Related]
11. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.
Erickson DR; Ordille S; Martin A; Bhavanandan VP
J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216
[TBL] [Abstract][Full Text] [Related]
12. [Early diagnosis of impaired glomerular and renal tubule function in patients with acromegaly].
Sindelka G; Skrha J; Hilgertová J; Justová V
Cas Lek Cesk; 1996 Oct; 135(20):657-9. PubMed ID: 8998811
[TBL] [Abstract][Full Text] [Related]
13. Diabetic microangiopathy and urinary glycosaminoglycans.
Kahaly G; Hansen C; Otto E; Förster G; Beyer J; Hommel G
Exp Clin Endocrinol Diabetes; 1997; 105(3):145-51. PubMed ID: 9228510
[TBL] [Abstract][Full Text] [Related]
14. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis.
Honkanen EO; Teppo AM; Grönhagen-Riska C
Kidney Int; 2000 Jun; 57(6):2343-9. PubMed ID: 10844604
[TBL] [Abstract][Full Text] [Related]
15. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
[TBL] [Abstract][Full Text] [Related]
16. Demographic and Clinicopathologic features of membranous glomerulonephritis.
Azad NS; Muzaffar S; Pervez S; Ahmed A; Rabbani A; Ali A
J Coll Physicians Surg Pak; 2004 Jan; 14(1):35-8. PubMed ID: 14764259
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic membranous glomerulonephritis: a quantitative study of glomerular and interstitial lesions.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 1995; 46(3):173-7. PubMed ID: 7496737
[TBL] [Abstract][Full Text] [Related]
18. Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis?
Davenport A; Maciver AG; Hall CL; MacKenzie JC
Clin Nephrol; 1994 May; 41(5):271-6. PubMed ID: 8050206
[TBL] [Abstract][Full Text] [Related]
19. [Urinary excretion of glycosaminoglycans in patients with chronic pyelonephritis and chronic glomerulonephritis].
Pavlov SB
Klin Med (Mosk); 1998; 76(2):41-3. PubMed ID: 9553361
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis.
Björnsson S
Anal Biochem; 1998 Feb; 256(2):229-37. PubMed ID: 9473282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
